drugset / Trial / NCT06593366

Fecal Microbiota Transplant for Anorexia Nervosa

NCT06593366

RandomizedParallel-groupQuadruple-blindOther

Summary

The purpose of this pilot randomized-controlled trial is to determine whether Fecal Microbiota Transplant (FMT) treatment demonstrates feasibility, acceptability, and prelinary effectiveness among patients with anorexia nervosa (AN). Specifically, the investigators aim to compare changes in weight, gut microbiome, urine, blood biomarkers and mood symptoms between participants receiving the FMT intervention and placebo.

Timeline

Start
2026-06-01
Primary completion
2027-06-01
Completion
2027-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fecal Microbiota Transplant Other / unclassified 15 g Oral

Indications